Latest On CSPC Pharmaceutical Group Limited (CSPCY):
General
- Name CSPC Pharmaceutical Group Limited
- Symbol CSPCY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorOther
- IndustryOther
- Fiscal Year EndDecember
Valuation
- Trailing PE 13.41
- Forward PE 20.75
- Price/Sales (Trailing 12 Mt.) 3.76
- Price/Book (Most Recent Quarter) 7.1
- Enterprise Value Revenue 0.59
- Enterprise Value EBITDA 2.65
Financials
- Most Recent Quarter 2017-12-31
- Revenue Per Share $0
- Gross Profit 9.35 billion
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 7.72 billion
- PEG Ratio 2.31
Share Statistics
- % Held by Insiders <1%
Technicals
- 52 Week High $5.55
- 52 Week Low $2.51
- 50 Day Moving Average 4.39
- 200 Day Moving Average 4.12
Dividends
- Forward Annual Dividend Yield 1.3%
- Dividend Date 2020-10-26
- ExDividend Date N/A
- Dividend Yield 0%
CSPC Pharmaceutical Group Limited (CSPCY) Dividend Calendar:
CSPCY's last dividend payment was made to shareholders on October 26, 2020.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
CSPC Pharmaceutical Group Limited (CSPCY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date | Jun 30 2019 | Dec 31 2017 | Sep 30 2017 | Jun 30 2017 | Mar 31 2017 |
---|---|---|---|---|---|
Research Development | N/A | N/A | N/A | N/A | N/A |
Income Before Tax | N/A | 887.53 million | 912.51 million | 859.47 million | 805.79 million |
Selling General Administrative | N/A | 1.56 billion | 1.33 billion | 1.13 billion | 1.03 billion |
Gross Profit | N/A | 2.79 billion | 2.43 billion | 2.15 billion | 1.98 billion |
Ebit | N/A | 901.51 million | 916.95 million | 876.24 million | 806.89 million |
Operating Income | N/A | 901.51 million | 916.95 million | 876.24 million | 806.89 million |
Income Tax Expense | N/A | 159.38 million | 179.25 million | 181.66 million | 164.95 million |
Total Revenue | N/A | 4.25 billion | 4.01 billion | 3.73 billion | 3.47 billion |
Cost of Revenue | N/A | 1.46 billion | 1.58 billion | 1.58 billion | 1.49 billion |
Total Other Income Expense Net | N/A | -13.99 million | -4.44 million | -16.77 million | -1.1 million |
Net Income From Continuing Operations | N/A | 728.15 million | 733.26 million | 677.81 million | 640.83 million |
Net Income Applicable to Common Shares | N/A | 726.82 million | 730.77 million | 675.05 million | 637.88 million |
Balance Sheet:
Date | Jun 30 2020 | Dec 31 2019 | Jun 30 2019 | Dec 31 2017 | Sep 30 2017 |
---|---|---|---|---|---|
Total Liabailities | 8.46 billion | 6.8 billion | 6.81 billion | 6.14 billion | N/A |
Total Stockholder Equity | 19.97 billion | 18.46 billion | 16.47 billion | 15.32 billion | 11.05 billion |
Other Current Liabilities | N/A | N/A | N/A | 2.43 billion | N/A |
Total Assets | 29.17 billion | 26.32 billion | 24.32 billion | 21.54 billion | N/A |
Common Stock | N/A | N/A | N/A | 12.92 billion | N/A |
Other Current Assets | N/A | N/A | N/A | 274.98 million | N/A |
Retained Earnings | N/A | N/A | N/A | N/A | N/A |
Other Liabilities | N/A | N/A | N/A | 315.58 million | N/A |
Other Assets | N/A | N/A | N/A | 593.8 million | N/A |
Cash | 5.95 billion | 4.12 billion | 4.03 billion | 5.24 billion | N/A |
Total Current Liabilities | 7.9 billion | 6.24 billion | 6.14 billion | 5.76 billion | N/A |
Other Stockholder Equity | N/A | N/A | N/A | 2.4 billion | N/A |
Property, Plant & Equipment | N/A | N/A | N/A | 6.66 billion | N/A |
Total Current Assets | 16.49 billion | 13.7 billion | 13.04 billion | 13.63 billion | N/A |
Long Term Investments | N/A | N/A | N/A | 426.72 million | N/A |
Net Tangible Assets | N/A | N/A | N/A | 15.1 billion | 10.8 billion |
Short Term Investments | 387000 | 536000 | 533000 | 1.32 billion | N/A |
Long Term Debt | N/A | N/A | N/A | 59.81 million | N/A |
Inventory | 2.1 billion | 2.54 billion | 2.47 billion | 2.9 billion | N/A |
Accounts Payable | 1.57 billion | 1.43 billion | 2.28 billion | 1.55 billion | N/A |
CSPC Pharmaceutical Group Limited (CSPCY) Chart:
CSPC Pharmaceutical Group Limited (CSPCY) News:
Below you will find a list of latest news for CSPC Pharmaceutical Group Limited (CSPCY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
CSPC Pharmaceutical Group Limited (CSPCY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
CSPC Pharmaceutical Group Limited (CSPCY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|